0.8371
price down icon13.72%   -0.1332
after-market Handel nachbörslich: .86 0.023 +2.74%
loading

Barinthus Biotherapeutics Plc Adr Aktie (BRNS) Neueste Nachrichten

pulisher
Nov 15, 2024

New trial shows promise for chronic hepatitis B treatment - Investing.com India

Nov 15, 2024
pulisher
Oct 01, 2024

Barinthus Bio completes enrollment for two clinical trials - Investing.com India

Oct 01, 2024
pulisher
Sep 25, 2024

Barinthus Bio intiates Phase 1 clinical trial of VTP-1000 for treatment of coeliac disease - European Pharmaceutical Manufacturer

Sep 25, 2024
pulisher
Sep 24, 2024

Barinthus Bio launches Phase 1 celiac disease therapy trial - Investing.com

Sep 24, 2024
pulisher
Sep 05, 2024

Barinthus Biotherapeutics appoints new COO - Investing.com

Sep 05, 2024
pulisher
Sep 05, 2024

BRNS Stock Touches 52-Week Low at $1.14 Amid Market Challenges - Investing.com UK

Sep 05, 2024
pulisher
Jun 21, 2024

Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket ... - Benzinga

Jun 21, 2024
pulisher
Jun 21, 2024

Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket By ... - Investing.com UK

Jun 21, 2024
pulisher
Jun 21, 2024

Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket - Benzinga

Jun 21, 2024
pulisher
Jun 12, 2024

Barinthus Bio refocuses on hepatitis B and celiac disease treatments By Investing.com - Investing.com

Jun 12, 2024
pulisher
Jun 12, 2024

Barinthus Bio Announces Strategic Pipeline Prioritization Following Positive Interim Data from VTP-300 in Chronic Hepatitis B Virus Infections - GlobeNewswire Inc.

Jun 12, 2024
pulisher
May 31, 2024

Market Update: Barinthus Biotherapeutics Plc. ADR (BRNS) Sees Negative Movement, Closing at 2.00 – DWinneX - The Dwinnex

May 31, 2024
pulisher
May 22, 2024

Barinthus Bio to Present VTP-300 Clinical Data Updates at EASL Congress 2024 - Investing.com India

May 22, 2024
pulisher
May 13, 2024

Barinthus Bio Reports First Quarter 2024 Financial Results and Update on Corporate Developments - Investing.com India

May 13, 2024
pulisher
May 01, 2024

Kintara Therapeutics restructures share designations By Investing.com - Investing.com

May 01, 2024
pulisher
Mar 19, 2024

Synlogic, Inc. (SYBX) Reports Q4 Loss, Tops Revenue Estimates - Zacks Investment Research

Mar 19, 2024
pulisher
Mar 18, 2024

Tango Therapeutics, Inc. (TNGX) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance

Mar 18, 2024
pulisher
Mar 13, 2024

Spero Therapeutics, Inc. (SPRO) Q4 Earnings and Revenues Top Estimates - Yahoo Finance

Mar 13, 2024
pulisher
Jan 05, 2024

ANVS Stock Quote Price and Forecast - CNN

Jan 05, 2024
pulisher
Oct 12, 2023

TPST Stock Quote Price and Forecast - CNN

Oct 12, 2023
pulisher
Apr 30, 2021

Vaccitech (VACC) Stock Price, News & Analysis - MarketBeat

Apr 30, 2021
pulisher
Jul 27, 2011

ADVFNFree stock and cryptocurrency prices, charts, market news and streaming real-time quotes. - ADVFN

Jul 27, 2011
$18.98
price up icon 3.66%
$76.97
price up icon 1.45%
$39.51
price up icon 7.22%
$359.21
price down icon 1.11%
$187.69
price down icon 0.81%
$101.87
price up icon 2.16%
Kapitalisierung:     |  Volumen (24h):